Antibacterial activity of recently approved antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) strains: A systematic review and meta-analysis.

导出 OA

翻译打印收藏纠错

作者： Fei,Liu ^[1] ; Sajad,Rajabi ^[2] ; Chunhua,Shi ^[3] ; Ghazale,Afifirad ^[4] ; Nazanin,Omidi ^[5] ; Ebrahim,Kouhsari ^[6] ; Saeed,Khoshnood ^[7] ; Khalil,Azizian ^[5]

作者单位： Department of Biomedical Engineering, Changzhi Medical College, Changzhi, 046013, Shanxi, China. ^[1] International Medical Campus, Iran University of Medical Sciences, Tehran, Iran. ^[2] Department of Biomedical Engineering, Changzhi Medical College, Changzhi, 046013, Shanxi, China. liufei126@163.com. ^[3] Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. ^[4] Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran. ^[5] Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran. ^[6] Department of Laboratory Sciences, Faculty of Paramedicine, Golestan University of Medical Sciences, Gorgan, Iran. ^[7] Department of Microbiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. k.azizian86@gmail.com. ^[8]

关键词 Antibacterial activity Dalbavancin Lipoglycopeptide MRSA Oritavancin Tedizolid Telavancin

主题词抗菌药(Anti-Bacterial Agents);人类(Humans);耐甲氧西林金黄色葡萄球菌(Methicillin-Resistant Staphylococcus aureus);微生物敏感性试验(Microbial Sensitivity Tests);葡萄球菌感染(Staphylococcal Infections)

DOI 10.1186/s12941-022-00529-z

PMID 35978400

发布时间 2022-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交